Oral Azacitidine Plus CHOP as Front-Line Treatment for Peripheral T-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma
Blood 2023 Feb 16;[EPub Ahead of Print], J Ruan, AJ Moskowitz, N Mehta-Shah, L Sokol, Z Chen, N Kotlov, G Nos, M Sorokina, V Maksimov, A Sboner, M Sigouros, K van Besien, SM Horwitz, SC Rutherford, E Mulvey, MV Revuelta, JZ Xiang, A Alonso, AM Melnick, O Elemento, GG Inghirami, JP Leonard, L Cerchietti, P MartinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.